Literature DB >> 9123841

Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.

L Zhang1, Y Huang, H Yuan, S Tuttleton, D D Ho.   

Abstract

The identification of HIV-1-infected individuals who remain asymptomatic despite prolonged infection presents a unique opportunity to understand virologic and host factors involved in the pathogenesis of AIDS. We have previously identified 10 long-term survivors (LTS) who are clinically healthy and immunologically normal despite 13 to 15 years of HIV-1 infection. In this study, we examined three accessory genes of HIV-1, vif, vpr, and vpu, in these LTS. A total of 52 vif, 54 vpr, and 55 vpu nucleotide sequences were obtained from the peripheral blood mononuclear cells of these patients. Analysis of these sequences revealed no gross deletions or insertions. Most of the clones were full-length with an intact open reading frame. Phylogenetic analyses of the vif, vpr, and vpu sequences from the LTS suggested that the HIV-1 strains found in the study subjects are not significantly different from those found in patients with AIDS and that the viruses in the LTS are unlikely to share a common genetic origin. Furthermore, a similar degree of overall genetic diversity between viruses from the LTS and AIDS patients suggests that there is unlikely a significant correlation between the degree of genetic diversity and the rate of disease development. Factors other than genetic divergence, such as viral load and phenotype, are likely to impact more on disease status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123841     DOI: 10.1006/viro.1996.8378

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.

Authors:  Julian J Lum; Oren J Cohen; Zilin Nie; Joel G Weaver; Timothy S Gomez; Xiao-Jian Yao; David Lynch; André A Pilon; Nanci Hawley; John E Kim; Zhaoxia Chen; Michael Montpetit; Jaime Sanchez-Dardon; Eric A Cohen; Andrew D Badley
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  The mitochondriotoxic domain of Vpr determines HIV-1 virulence.

Authors:  Catherine Brenner; Guido Kroemer
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy.

Authors:  Celia Chui; Peter K Cheung; Chanson J Brumme; Theresa Mo; Zabrina L Brumme; Julio S G Montaner; Andrew D Badley; P Richard Harrigan
Journal:  AIDS Res Hum Retroviruses       Date:  2006-07       Impact factor: 2.205

4.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

Review 5.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

6.  HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.

Authors:  Xin Wang; Shailbala Singh; Hae-Yun Jung; Guojun Yang; Sohee Jun; K Jagannadha Sastry; Jae-Il Park
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 8.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

9.  Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.

Authors:  John S Albin; Guylaine Haché; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

10.  Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.

Authors:  Andreas Jekle; Birgit Schramm; Prerana Jayakumar; Verena Trautner; Dominique Schols; Erik De Clercq; John Mills; Suzanne M Crowe; Mark A Goldsmith
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.